Values, preferences and current hepatitis B and C testing practices in low- and middle-income countries: Results of a survey of end users and implementers

BMC Infectious Diseases

Volumn 17, Issue , 2017, Pages

  Reipold, Elena Ivanova ^a   Trianni, Alessandra ^a   Krakower, Douglas ^b   Ongarello, Stefano ^a   Roberts, Teri ^a,d   Easterbrook, Philippa ^c   Denkinger, Claudia ^a  

^a Tuberculosis Program   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d MSF Access Campaign   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AWARENESS; BLOOD DONOR; CLINICAL ARTICLE; E-MAIL; EDUCATION; FEMALE; FUNDING; GOVERNMENT; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; MALE; MIDDLE INCOME COUNTRY; NONHUMAN; SCALE UP; SOFTWARE; VIRUS DIAGNOSIS; WORLD HEALTH ORGANIZATION; ALGORITHM; DIAGNOSTIC TEST; ECONOMICS; HEPATITIS B; HEPATITIS C; INCOME; POVERTY; QUESTIONNAIRE; SEROLOGY;

ALGORITHMS; DIAGNOSTIC TESTS, ROUTINE; HEPATITIS B; HEPATITIS C; HUMANS; INCOME; POVERTY; SEROLOGIC TESTS; SURVEYS AND QUESTIONNAIRES; WORLD HEALTH ORGANIZATION;

EID: 85032725170     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-017-2769-y     Document Type: Article

References (21)

1. World Health Organization. Global Hepatitis Report, 2017. 2017: Geneva. http://apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1 ). Accessed 22 June 2017.
2. Lim SG. HCV management in resource-constrained countries. Hepatol Int. 2017;Feb 21, Epub. doi: 10.1007/s12072-017-9787-0.
3. Zampino R, Sagnelli C, Boemio A, Sagnelli E, Coppola N. Treatment of chronic HBV infection in developing countries. Ann Hepatol. 2016;15:816-23.
4. Chen C-J, Yang H-I, Su J, Jen C-L, You S-L, Lu S-N, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
5. Kosack CS, Nick S. Evaluation of two rapid screening assays for detecting hepatitis C antibodies in resource-constrained settings. Trop Med Int Heal. 2016;21:603-9.
6. Khuroo MS, Khuroo NS, Khuroo MS. Accuracy of Rapid Point-of-Care Diagnostic Tests for Hepatitis B Surface Antigen-A Systematic Review and Meta-analysis. J Clin Exp Hepatol. 2014;4:226-40.
7. Khuroo MS, Khuroo NS, Khuroo MS. Diagnostic accuracy of point-of-care tests for hepatitis C virus infection: A systematic review and meta-analysis. PLoS One. 2015;10(3):e0121450.
8. Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol. 2008;103:1283-97.
9. World Health Organization. Guidelines on hepatitis B and C testing. Geneva; 2017. http://apps.who.int/iris/bitstream/10665/254621/1/9789241549981-eng.pdf?ua=1. Accessed 22 June 2017.
10. nd edition. Geneva; 2014. Available from http://apps.who.int/medicinedocs/documents/s22083en/s22083en.pdf. Accessed 14 Nov 2016.
11. Reipold E, Easterbrook P, Trianni A, Paneer N, Krarower D, Ongarello S, et al. Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile. BMC Infect. Dis. 2017; Vol17 Suppl 1. doi: 10.1186/s12879-017-2770-5.
12. World Health Organization. Screening Donated Blood for Transfusion- Transmissible Infections Recommendations. Geneva; 2010. Availablre from http://www.who.int/bloodsafety/ScreeningTTI.pdf. Accessed 14 Nov 2016.
13. Kupek E. Residual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives. ISRN Infect Dis. 2013;2013:15.
14. Marwaha N, Sachdev S. Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World J Gastroenterol. 2014;20:2948-54.
15. Cloherty G, Talal A, Coller K, Steinhart C, Hackett J, Dawson G, et al. Role of Serologic and Molecular Diagnostic Assays in Identification. J Clin Microbiol. 2016;54:265-73.
16. Freiman JM, Tran TM, Schumacher SG, White LF, Ongarello S, Cohn J, et al. Hepatitis C Core Antigen Testing for Diagnosis of Hepatitis C Virus Infection. Ann Intern Med. 2016;165(5):345-55.
17. Sidharthan S, Kohli A, Sims Z, Nelson A, Osinusi A, Masur H, et al. Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy. Clin Infect Dis. 2015;60:1743-51.
18. Denkinger C, Nicolau I, Ramsay A, Chedore P, Pai M. Are peripheral microscopy centres ready for next generation molecular tuberculosis diagnostics? Eur Respir J. 2013;42:544-7.
19. Usdin M, Guillerm M, Calmy A. Patient needs and point-of-care requirements for HIV load testing in resource-limited settings. J Infect Dis. 2010;201:S73-7.
20. Médecins Sans Frontières (MSF). Putting HIV and HCV to the Test: A Product Guide for Point-of-Care CD4 and Laboratory-Based and Point-of-Care Virological HIV and HCV Tests; 2015. p. 1-100.
21. World Bank Country and Lending Groups - World Bank Data Help Desk [Internet]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519. [Accessed 22 June 2017].